Hos cirrhotiske patienter med moderat (Child- Pugh B) nedsat leverfunktion, var ubundet Cmax og AUC 2- 3 gange højere end hos normale personer.
Following rosiglitazone treatment in cirrhotic patients with moderate (Child- Pugh B) hepatic impairment, unbound Cmax and AUC were 2- and 3-fold higher than in normal subjects.